UroGen Pharma Ltd. – Filings and Transcripts

NASDAQ: URGN
Share price (3/18/26): $18.48
Market cap (3/18/26): $900 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024 – amended

Prospectuses and Registrations Filter

Registration of securities for employees

Automatic shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Robinson James A. Jr.

Barrett Elizabeth A.

The Toronto Dominion Bank

Smith Jason Drew

Schoenberg Mark

News Filter

Announces ZUSDURITM Launch Is On-Track and Reports Fourth Quarter and Full Year 2025 Financial Results

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement

Reports Third Quarter 2025 Financial Results as ZUSDURI™ Launch Gains Momentum

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Expands Commercial Portfolio With Launch of ZUSDURI™ and Reports Second Quarter 2025 Financial Results

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC